Medifast, Inc. 2006 Annual Report (10-K) Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2006. Medifast, Inc. is a Delaware corporation engaged in the production, distribution, and sale of weight management, disease management, and meal replacement products. The company operates through multiple channels including direct-to-consumer (Medifast Direct), a physician-led network (Take Shape for Life), physician clinics, and corporately owned weight control centers. The company manufactures products in Owings Mills, Maryland, and distributes them nationwide.
Key Financial Metrics
| Metric | 2006 | 2005 |
|---|---|---|
| Revenue | $74,086,000 | $40,129,000 |
| Gross Profit | $55,849,000 | $29,968,000 |
| Gross Margin | 75.4% | 74.7% |
| Operating Income | $8,112,000 | $4,074,000 |
| Net Income | $5,082,000 | $2,727,000 |
| Diluted EPS | $0.38 | $0.19 |
| Cash from Operations | $5,845,000 | $3,213,000 |
| Total Assets | $36,927,000 | $30,545,000 |
| Total Debt (Long-term + Current) | $5,313,000 | $5,171,000 |
| Working Capital | $9,612,000 | $9,996,000 |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 85% year-over-year, driven primarily by a 142% increase in the direct marketing channel and a 46% increase in the Take Shape for Life division.
- Advertising Spend: Advertising expenses surged from $3.8 million in 2005 to $14.3 million in 2006 to fuel customer acquisition across TV, print, and web media.
- Profitability: Net income increased 108% to $5.1 million. Gross margin improved slightly to 75.4% due to volume discounts on raw materials.
- One-Time Loss: The company recorded a $323,000 loss on the sale of the Consumer Choice Systems division to a former board member, structured as a 10-year promissory note.
- Stock Compensation: The company adopted FASB 123(R) in 2006, resulting in $533,000 in stock compensation expense, compared to $0 in 2005.
- Infrastructure Investment: Significant capital expenditures ($6.7 million net cash used in investing) were made for a new ERP system, manufacturing lines, and distribution facility improvements.
Guidance, Outlook, and Risks
- Outlook: Management expects to increase the advertising budget in 2007. The company has scaled infrastructure to handle approximately $250 million to $300 million in sales volume.
- Tax Rate: The effective tax rate for 2006 was 31%. Management anticipates a tax rate of approximately 36-39% in 2007.
- Seasonality: Historically, November/December are slow months, while January/February are strong. The company noted a decrease in seasonality in 2006 due to increased consumer awareness of health benefits.
- Risks: Key risks include dependence on advertising effectiveness, potential health-related claims from customers, competition from fad diets or pharmaceutical solutions, and the ability to manage rapid growth without operational strain (e.g., call center capacity).
- Unusual Items: The sale of Consumer Choice Systems and the implementation of the new ERP system were significant non-recurring or one-time events impacting cash flow and expenses.
Investor Verification Checklist
- Verify the sustainability of the 85% revenue growth rate given the 276% increase in advertising spend.
- Confirm the company's ability to maintain gross margins as advertising costs potentially rise or volume discounts diminish.
- Review the terms and collectability of the $1.8 million note receivable from the sale of Consumer Choice Systems.
- Assess the impact of the new FASB 123(R) stock compensation rules on future earnings per share.
- Monitor the company's cash position, which decreased to $1.1 million, against its $5 million line of credit and capital expenditure needs.
- Validate the effectiveness of the new ERP system in managing inventory and order processing during peak "diet season" in Q1 2007.